Bioventix PLC (AIM:BVXP)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 2,025.00
-25.00 (-1.22%)
Nov 4, 2026, 4:54 PM GMT
Bioventix Ratios and Metrics
Market cap in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 106 | 86 | 144 | 230 | 201 | 180 | |
Market Cap Growth | -1.22% | -40.00% | -37.44% | 14.29% | 11.82% | -13.10% |
Enterprise Value | 101 | 81 | 139 | 224 | 196 | 175 |
Last Close Price | 19.45 | 16.50 | 25.51 | 38.74 | 32.58 | 27.88 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.10 | 11.32 | 18.95 | 28.37 | 24.00 | 23.42 |
Forward PE | 14.14 | 13.23 | 18.42 | 25.47 | 24.22 | 26.92 |
PS Ratio | 8.16 | 6.65 | 10.96 | 16.88 | 15.68 | 15.34 |
PB Ratio | 9.27 | 7.55 | 12.44 | 19.14 | 16.66 | 15.20 |
P/TBV Ratio | 9.27 | 7.55 | 12.44 | 19.14 | 16.66 | 15.20 |
P/FCF Ratio | 13.42 | 10.94 | 20.49 | 27.58 | 25.79 | 23.82 |
P/OCF Ratio | 13.30 | 10.84 | 20.43 | 27.52 | 25.76 | 23.78 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 7.75 | 6.24 | 10.56 | 16.47 | 15.28 | 14.91 |
EV/EBITDA Ratio | 9.97 | 8.03 | 13.63 | 20.87 | 19.20 | 18.73 |
EV/EBIT Ratio | 10.03 | 8.07 | 13.75 | 21.10 | 19.45 | 19.03 |
EV/FCF Ratio | 12.75 | 10.26 | 19.76 | 26.92 | 25.13 | 23.15 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / EBITDA Ratio | 0.00 | 0.00 | - | - | - | - |
Net Debt / Equity Ratio | -0.46 | -0.46 | -0.44 | -0.50 | -0.47 | -0.52 |
Net Debt / EBITDA Ratio | -0.52 | -0.52 | -0.50 | -0.56 | -0.56 | -0.66 |
Net Debt / FCF Ratio | -0.67 | -0.67 | -0.72 | -0.72 | -0.73 | -0.81 |
Asset Turnover | 1.01 | 1.01 | 0.99 | 1.01 | 0.97 | 0.90 |
Inventory Turnover | 1.59 | 1.59 | 1.84 | 1.57 | 1.61 | 1.79 |
Quick Ratio | 4.78 | 4.78 | 4.68 | 4.37 | 5.74 | 5.50 |
Current Ratio | 8.53 | 8.53 | 9.17 | 7.42 | 10.08 | 9.43 |
Return on Equity (ROE) | 66.31% | 66.31% | 64.40% | 67.29% | 70.10% | 64.92% |
Return on Assets (ROA) | 48.78% | 48.78% | 47.35% | 49.17% | 47.68% | 44.10% |
Return on Invested Capital (ROIC) | 121.27% | 118.22% | 121.31% | 131.39% | 138.16% | 137.82% |
Return on Capital Employed (ROCE) | 87.80% | 87.80% | 87.20% | 88.50% | 83.30% | 77.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 7.09% | 8.83% | 5.28% | 3.52% | 4.17% | 4.27% |
FCF Yield | 7.45% | 9.14% | 4.88% | 3.63% | 3.88% | 4.20% |
Dividend Yield | 7.41% | 9.09% | 5.46% | 3.52% | 3.95% | 3.65% |
Payout Ratio | 102.92% | 102.92% | 108.05% | 101.86% | 100.85% | 103.18% |
Buyback Yield / Dilution | -0.17% | -0.17% | 0.08% | -0.14% | -0.56% | 0.03% |
Total Shareholder Return | 7.23% | 8.92% | 5.53% | 3.38% | 3.38% | 3.68% |